Trump appoints Elon Musk and Vivek Ramaswamy to lead the Department of Government Efficiency, aiming to cut bureaucracy and ...

Trump made the announcement on social media, fulfilling a promise during the campaign to give Musk sweeping oversight of ...

Trump made the announcement on social media, fulfilling a promise during the campaign to give Musk sweeping oversight of ...

Increased operational expenses and reduced cash reserves were cited. Roivant Sciences reports improved EPS for the second ...

Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.26 per share a year ago. These ...

More recently, he has held consulting, advisory and investment partner roles with organisations including BIO, MIT, Roivant ...

Roivant Sciences Ltd (NASDAQ:ROIV) is set to release its Q2 2025 earnings on Nov 12, 2024. The consensus estimate for Q2 2025 ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...

Vivek Ramaswamy (American entrepreneur who founded Roivant Sciences) will also be very influential and will surely support ...

Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD – The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the Phase ...

Strive Enterprises, a financial services company co-founded by former Republican presidential candidate Vivek Ramaswamy, has announced plans to move its headquarters to Dallas.

Organon, which is seeking approval of Vtama as a treatment for atopic dermatitis, said the FDA set a new target action date of March 12 for a decision after requesting the final datasets and ...